Bernice Morrow

Dr. Bernice Morrow is a Professor at Albert Einstein College of Medicine, holding appointments in the Department of Genetics, Department of Obstetrics & Gynecology and Women's Health, and Department of Pediatrics (Pediatric Cardiology). She serves as the Sidney L. and Miriam K. Olson Chair in Cardiology and directs the Division of Translational Genetics. Her research focuses on understanding the genetic and epigenetic mechanisms underlying birth defects, particularly in 22q11.2 deletion syndrome (22q11.2DS). She leads the Morrow Lab, which employs functional genomics and single-cell analysis to study genes such as TBX1, DGCR8, and CRKL in congenital heart defects and neural development.

Education and training details are not explicitly listed in the provided texts, but her academic roles indicate advanced expertise in genetics and developmental biology. She collaborates with institutions like the Montefiore Einstein Regional Center for 22q11.2DS and the International Chromosome 22q11.2 Consortium.

Research interests include identifying genetic modifiers of 22q11.2DS severity, studying T-box transcription factors in heart and inner ear development, and analyzing single-cell omics data to uncover lineage-specific genetic programs. Collaborations span cardiology, genetics, and clinical research.

Key publications highlight her work on TBX1’s role in cardiac progenitor cells, CRKL dosage sensitivity in heart defects, and genomic analyses of IQ variance in 22q11.2DS patients. Her lab members include PhD candidates and postdoctoral fellows working on projects ranging from microRNA functions to epigenetic regulation.

Lab activities focus on interdisciplinary approaches to bridge basic science and clinical outcomes, with a focus on translational genetics. No awards are explicitly mentioned in the provided texts.